These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 19590269)

  • 41. Key scientific findings and policy- and health-relevant insights from the U.S. Environmental Protection Agency's Particulate Matter Supersites Program and related studies: an integration and synthesis of results.
    Solomon PA; Hopke PK; Froines J; Scheffe R
    J Air Waste Manag Assoc; 2008; 58(13 Suppl):S3-92. PubMed ID: 19202993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Framework for use of toxicity screening tools in context-based decision-making.
    Doull J; Borzelleca JF; Becker R; Daston G; DeSesso J; Fan A; Fenner-Crisp P; Holsapple M; Holson J; Craig Llewellyn G; MacGregor J; Seed J; Walls I; Woo YT; Olin S
    Food Chem Toxicol; 2007 May; 45(5):759-96. PubMed ID: 17215066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incorporating sediment stability within the management of contaminated sediment sites: a synthesis approach.
    Bohlen WF; Erickson MJ
    Integr Environ Assess Manag; 2006 Jan; 2(1):24-8. PubMed ID: 16640313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulatory models and the environment: practice, pitfalls, and prospects.
    Holmes KJ; Graham JA; McKone T; Whipple C
    Risk Anal; 2009 Feb; 29(2):159-70. PubMed ID: 19144069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. U.S. Environmental Protection Agency's activities to prepare for regulatory and risk assessment applications of genomics information.
    Benson WH; Gallagher K; McClintock JT
    Environ Mol Mutagen; 2007 Jun; 48(5):359-62. PubMed ID: 17567849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the influence of Environmental Impact Assessments on science and policy: an analysis of the Three Gorges Project.
    Tullos D
    J Environ Manage; 2009 Jul; 90 Suppl 3():S208-23. PubMed ID: 19026482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose assessment for reentry or reoccupancy and recovery of urban areas contaminated by a radiological dispersal device: the need for a consensus approach.
    Sullivan T; Musolino SV; DeFranco J
    Health Phys; 2008 May; 94(5):411-7. PubMed ID: 18403962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Precaution, law and principles of good administration.
    Fisher E
    Water Sci Technol; 2005; 52(6):19-24. PubMed ID: 16304930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Australian model of immunization advice and vaccine funding.
    Nolan TM
    Vaccine; 2010 Apr; 28 Suppl 1():A76-83. PubMed ID: 20413003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What does the precautionary principle mean for evidence-based dentistry?
    Tickner J; Coffin M
    J Evid Based Dent Pract; 2006 Mar; 6(1):6-15. PubMed ID: 17138389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A guidance for assessing and communicating uncertainties.
    Janssen PH; Petersen AC; van der Sluijs JP; Risbey JS; Ravetz JR
    Water Sci Technol; 2005; 52(6):125-31. PubMed ID: 16304944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decision-making in environmental health.
    Schwartz E; Corvalán C
    World Health Stat Q; 1995; 48(2):164-70. PubMed ID: 8585235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Science, senators, and uncertainty.
    Brandon RN
    Fed Proc; 1979 Nov; 38(12):2564-6. PubMed ID: 499570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
    Lopert R
    Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From optimization to adaptation: shifting paradigms in environmental management and their application to remedial decisions.
    Linkov I; Satterstrom FK; Kiker GA; Bridges TS; Benjamin SL; Belluck DA
    Integr Environ Assess Manag; 2006 Jan; 2(1):92-8. PubMed ID: 16640324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analysis of public-interest group positions on radiation protection.
    Florig HK
    Health Phys; 2006 Nov; 91(5):508-13. PubMed ID: 17033464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How do drug policy makers access research evidence?
    Ritter A
    Int J Drug Policy; 2009 Jan; 20(1):70-5. PubMed ID: 18226519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the design of computer-based models for integrated environmental science.
    McIntosh BS; Jeffrey P; Lemon M; Winder N
    Environ Manage; 2005 Jun; 35(6):741-52. PubMed ID: 15940402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspectives of U.S. government agencies on the potential role of greater scientific understanding of low-dose radiation effects in establishing regulatory health protection guidance.
    Tenforde TS; Brooks AL
    Health Phys; 2009 Nov; 97(5):516-8. PubMed ID: 19820462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.